{"schema_version":"1","generated_at":"2026-11-21T11:35:52.835Z","data_as_of":null,"url":"https://www.findmykol.com/kol/barry-rutherford","json_url":"https://www.findmykol.com/kol/barry-rutherford/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"barry-rutherford","name":"Barry Rutherford","credential":"MD","specialty":"Interventional Cardiology","specialty_raw":"Interventional Cardiology","therapeutic_area":"Cardiology","therapeutic_areas":["Cardiology"],"institution":"University of Missouri–Kansas City","institution_url":"https://www.findmykol.com/institution/university-of-missouri-kansas-city","city":"Kansas City","state":"MO","region":{"label":"Midwest","url":"https://www.findmykol.com/region/midwest"}},"identifiers":{"on_file":["npi","openalex"],"values":"Shown on the profile page to a signed-in account."},"summary":"Barry Rutherford is a Cardiology physician affiliated with University of Missouri–Kansas City. OpenAlex indexes 126 publications with 7,792 citations (h-index 45). By OpenAlex citation count, this profile ranks in the top 10% of Interventional Cardiology profiles in the FindMyKOL directory.","overview":null,"focus":{"indications":[],"research_topics":["Cardiology"]},"scholarship":{"works_count":126,"cited_by_count":7792,"h_index":45,"latest_activity_year":2011,"citation_standing":{"top_percent":10,"cohort":"Interventional Cardiology","method":"https://www.findmykol.com/about#citation-standing"},"source":"works"},"prescribing":{"data_year":2023,"areas_total":3,"areas_shown":3,"areas":[{"area":"Cardiovascular","share_pct":93.8,"classes_total":9,"classes":[{"class":"Beta blocker","setting":"prescribed","share_pct":28,"drugs":[{"name":"Metoprolol Succinate","share_pct":44.2},{"name":"Carvedilol","share_pct":34.5},{"name":"Metoprolol Tartrate","share_pct":21.2}],"max_beneficiaries":null},{"class":"Statin","setting":"prescribed","share_pct":26.5,"drugs":[{"name":"Atorvastatin Calcium","share_pct":78.5},{"name":"Rosuvastatin Calcium","share_pct":11.2},{"name":"Simvastatin","share_pct":10.3}],"max_beneficiaries":null}]},{"area":"Blood & clotting","share_pct":3.2,"classes_total":1,"classes":[{"class":"P2Y12 inhibitor","setting":"prescribed","share_pct":3.2,"drugs":[{"name":"Clopidogrel","share_pct":100}],"max_beneficiaries":null}]},{"area":"Metabolism & gastrointestinal","share_pct":3,"classes_total":1,"classes":[{"class":"Proton pump inhibitor","setting":"prescribed","share_pct":3,"drugs":[{"name":"Pantoprazole Sodium","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"office","data_year":2022,"office_pct":100,"facility_pct":0},"source":"medicare"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Changes in myocardial ischemic burden following percutaneous coronary intervention of chronic total occlusions","year":2011,"journal":"Catheterization and Cardiovascular Interventions","source_url":"https://doi.org/10.1002/ccd.23002","status":"verified"},{"title":"Chronic Total Occlusion Angioplasty in the United States","year":2009,"journal":"JACC: Cardiovascular Interventions","source_url":"https://doi.org/10.1016/j.jcin.2009.02.008","status":"verified"},{"title":"The Harmonizing Outcomes with RevascularIZatiON and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial: Study design and rationale","year":2008,"journal":"American Heart Journal","source_url":"https://doi.org/10.1016/j.ahj.2008.02.008","status":"verified"},{"title":"Improvement in Survival Following Successful Percutaneous Coronary Intervention of Coronary Chronic Total Occlusions: Variability by Target Vessel","year":2008,"journal":"JACC: Cardiovascular Interventions","source_url":"https://doi.org/10.1016/j.jcin.2008.05.004","status":"verified"},{"title":"Comparison of Myocardial Reperfusion in Patients Undergoing Percutaneous Coronary Intervention in ST-Segment Elevation Acute Myocardial Infarction With Versus Without Diabetes Mellitus (from the EMERALD Trial)","year":2007,"journal":"The American Journal of Cardiology","source_url":"https://doi.org/10.1016/j.amjcard.2007.02.080","status":"verified"}],"source":"works"},"similar":[{"name":"John Spertus","slug":"john-spertus","institution":"University of Missouri–Kansas City","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/john-spertus","json_url":"https://www.findmykol.com/kol/john-spertus/profile.json"},{"name":"Gary Lofland","slug":"gary-lofland","institution":"University of Missouri–Kansas City","specialty":"Pediatric Surgery","url":"https://www.findmykol.com/kol/gary-lofland","json_url":"https://www.findmykol.com/kol/gary-lofland/profile.json"},{"name":"Jessica Hellings","slug":"jessica-hellings","institution":"University of Missouri–Kansas City","specialty":"Child & Adolescent Psychiatry","url":"https://www.findmykol.com/kol/jessica-hellings","json_url":"https://www.findmykol.com/kol/jessica-hellings/profile.json"},{"name":"Erika Hutt Centeno","slug":"erika-hutt-centeno","institution":"University of Missouri–Kansas City","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/erika-hutt-centeno","json_url":"https://www.findmykol.com/kol/erika-hutt-centeno/profile.json"},{"name":"Deepak Bhatt","slug":"deepak-bhatt","institution":"Icahn School of Medicine at Mount Sinai","specialty":"Interventional Cardiology","url":"https://www.findmykol.com/kol/deepak-bhatt","json_url":"https://www.findmykol.com/kol/deepak-bhatt/profile.json"},{"name":"Harlan Krumholz","slug":"harlan-krumholz","institution":"Yale School of Medicine","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/harlan-krumholz","json_url":"https://www.findmykol.com/kol/harlan-krumholz/profile.json"},{"name":"Martin Leon","slug":"martin-leon","institution":"Columbia University Irving Medical Center","specialty":"Interventional Cardiology","url":"https://www.findmykol.com/kol/martin-leon","json_url":"https://www.findmykol.com/kol/martin-leon/profile.json"},{"name":"Gregg Fonarow","slug":"gregg-fonarow","institution":"Ronald Reagan UCLA Medical Center","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/gregg-fonarow","json_url":"https://www.findmykol.com/kol/gregg-fonarow/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":45}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2023}},"methodology_url":"https://www.findmykol.com/about#methodology"}